By utilising our wholly-owned, harmonised laboratory facilities in the United States, Europe, Singapore and China, Eurofins Central Laboratory is able to accommodate clinical trials of any nature, size or complexity. With the increasing number of study protocols that involve a variety of esoteric testing, it is of pivotal importance to use globally standardised laboratory facilities that are situated close to the patients in all geographical regions.

The global footprint of Eurofins Central Laboratory ensures specimen integrity, optimal turnaround time for results, manageability of the logistic processes and control over associated costs.

The global quality system of Eurofins Central Laboratory is designed to encompass the relevant aspects of both international and country-specific quality standards. The quality system of Eurofins Central Laboratory is based on regulatory standards GCLP, GCP, and CLIA, and quality standards CAP, ISO/IEC17025 and ISO15189.